ArticlePLoS pathogens2025
Resolving the APN controversy in PEDV infection: Comparative kinetic characterization through single-virus tracking.
Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The cholesterol transporter Niemann-Pick C1 facilitates the entry of porcine epidemic diarrhea coronavirus.Journal of virology · 2026Article
- Article
- Epidemiological characteristics of co-infection between porcine epidemic diarrhea virus (PEDV) and other pathogens: a meta-analysis and systematic review.Porcine health management · 2026Article
- Cell entry mechanisms of porcine enteric coronaviruses.The Journal of biological chemistry · 2026Review
- Cav1.2 facilitates the binding and internalisation of porcine epidemic diarrhoea virus.Veterinary research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Aminopeptidase N (APN) plays multiple roles in various physiological processes, with its function as a viral receptor in several coronaviruses being one of the most prominent. However, the role of porcine APN (pAPN) in porcine epidemic diarrhea virus (PEDV) has remained controversial. Single-virus tracking enables a more comprehensive dynamic dissection of pAPN utilization during virus entry. In this study, a comparative analysis of pAPN usage by PEDV, transmissible gastroenteritis virus (TGEV), and swine acute diarrhea syndrome coronavirus (SADS-CoV) provides more precise and quantitative insights into pAPN's specific role in PEDV entry. Here, we used molecular docking and surface plasmon resonance (SPR) to demonstrate that pAPN binds to PEDV, with lower affinity than to TGEV. However, pAPN facilitates PEDV replication through internalization only in susceptible cells, not in non-susceptible cells. Using single-virus tracking, we observed that pAPN triggers PEDV internalization via clathrin- and caveolae-mediated endocytosis, resembling a receptor-mediated process. pAPN participates in 35% of PEDV internalization events, but mediates 80% of TGEV internalization, with pAPN-mediated PEDV internalization occurring approximately 60 s slower than TGEV. The dynamic differences in the internalization of PEDV and TGEV mediated by pAPN primarily arise during the binding stage prior to the initiation of accelerated directional movement, whereas their durations of movement are comparable. Additionally, we found that the internalization dynamics of porcine deltacoronavirus (PDCoV), which also uses pAPN as a receptor, are similar to those of TGEV. These findings resolve the controversy surrounding pAPN's role in PEDV entry, and highlight the dynamic differences in PEDV, TGEV, PDCoV, and SADS-CoV internalization via pAPN at single-virus level, providing a novel theoretical basis for the potential receptor evaluation from kinetic perspective, which could significantly contribute to the development of strategies against future PEDV outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.